Exane Derivatives’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Exane Derivatives's MRK Position: Q2 2022 in Review
Exane Derivatives reduced its Merck (MRK) stake by 4.4% in Q2 2022, selling an estimated $267K and leaving 64,879 shares worth $5.91M. The position accounts for 3.4% of the portfolio, ranked #3.
Exane Derivatives first reported a position in MRK in Q4 2014 and has held it in 23 quarters since. The position peaked at $7.2M in Q1 2020. 3,013 funds tracked by Wall St. Rank hold MRK as of Q2 2022.
- Exane Derivatives held 64,879 shares of Merck worth $5.91M as of Q2 2022.
- Exane Derivatives sold 3,015 Merck shares in Q2 2022, an estimated $267K.
- Merck made up 3.4% of Exane Derivatives's portfolio in Q2 2022, its #3 holding.
- Exane Derivatives first reported a position in Merck in Q4 2014 and has held it in 23 quarters since.
- Exane Derivatives's Merck position peaked at $7.2M in Q1 2020.
- 3,013 funds tracked by Wall St. Rank held Merck as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.